Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-10384 in Postmenopausal Women with Vasomotor Symptoms
NCT06393673Phase 2Not yet recruiting
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- May 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HS-10384 in vasomotor symptoms, sponsored by Hansoh Pharmaceutical Group. Planned start May 2024; status: not yet recruiting.
02
Drugs
HS-10384
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT06393673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06393673.